Terms: = Leukemia AND REL, I-Rel, 5966, ENSG00000162924, C-Rel AND Diagnosis
12 results:
1. Clonal evolution dissection reveals that a high MSI2 level promotes chemoresistance in T-cell acute lymphoblastic leukemia.
Zhang J; Duan Y; Wu P; Chang Y; Wang Y; Hu T; Liu C; Chen X; Zong S; Chen X; Wu Y; Jin L; Lan Y; Liu X; Cheng X; Ding F; Li T; Chen X; Guo Y; Chen Y; Yang W; Zhang L; Zou Y; Cheng T; Zhu X; Zhang Y
Blood; 2024 Jan; 143(4):320-335. PubMed ID: 37801708
[TBL] [Abstract] [Full Text] [Related]
2. Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303.
Russler-Germain DA; Krysiak K; Ramirez C; Mosior M; Watkins MP; Gomez F; Skidmore ZL; Trani L; Gao F; Geyer S; Cashen AF; Mehta-Shah N; Kahl BS; Bartlett NL; Alderuccio JP; Lossos IS; Ondrejka SL; Hsi ED; Martin P; Leonard JP; Griffith M; Griffith OL; Fehniger TA
Blood Adv; 2023 Sep; 7(18):5524-5539. PubMed ID: 37493986
[TBL] [Abstract] [Full Text] [Related]
3. An alternative CYB5A transcript is expressed in aneuploid ALL and enriched in relapse.
Bartsch L; Schroeder MP; Hänzelmann S; Bastian L; Lázaro-Navarro J; Schlee C; Tanchez JO; Schulze V; Isaakidis K; Rieger MA; Gökbuget N; Eckert C; Serve H; Horstmann M; Schrappe M; Brüggemann M; Baldus CD; Neumann M
BMC Genom Data; 2022 Apr; 23(1):30. PubMed ID: 35436854
[TBL] [Abstract] [Full Text] [Related]
4. Validation of the "fitness criteria" for the treatment of older patients with acute myeloid leukemia: A multicenter study on a series of 699 patients by the Network Rete Ematologica Lombarda (rel).
Borlenghi E; Pagani C; Zappasodi P; Bernardi M; Basilico C; Cairoli R; Fracchiolla N; Todisco E; Turrini M; Cattaneo C; Da Vià M; Ciceri F; Passamonti F; Mancini V; Sciumè M; Cerqui E; Sciumè M; Rossi G
J Geriatr Oncol; 2021 May; 12(4):550-556. PubMed ID: 33097455
[TBL] [Abstract] [Full Text] [Related]
5. The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On behalf of the acute leukemia working party (ALWP) of the European group for blood and marrow transplantation (EBMT).
Poiani M; Labopin M; Battipaglia G; Beelen DW; Tischer J; Finke J; Brecht A; Forcade E; Ganser A; Passweg JR; Labussiere-Wallet H; Yakoub-Agha I; Schäfer-Eckart K; Kroeger N; Guffroy B; Ruggeri A; Esteve J; Nagler A; Mohty M
Am J Hematol; 2021 Jan; 96(1):40-50. PubMed ID: 32944990
[TBL] [Abstract] [Full Text] [Related]
6. Molecular remission at the end of treatment is a necessary goal for a good outcome in ELN favorable-risk acute myeloid leukemia: a real-life analysis on 201 patients by the Rete Ematologica Lombarda network.
Zappasodi P; Marbello L; Borlenghi E; Fumagalli M; Bernardi M; Fracchiolla N; Mancini V; Da Vià M; Ravano E; Cerqui E; Ferretti VV; Rocca B; Calvello C; Cazzola M; Castagnola C; Rossi G
Ann Hematol; 2018 Nov; 97(11):2107-2115. PubMed ID: 30009341
[TBL] [Abstract] [Full Text] [Related]
7. Array comparative genomic hybridization detects chromosomal abnormalities in hematological cancers that are not detected by conventional cytogenetics.
Shao L; Kang SH; Li J; Hixson P; Taylor J; Yatsenko SA; Shaw CA; Milosavljevic A; Chang CC; Cheung SW; Patel A
J Mol Diagn; 2010 Sep; 12(5):670-9. PubMed ID: 20724749
[TBL] [Abstract] [Full Text] [Related]
8. rel a is an independent biomarker of clinical outcome in chronic lymphocytic leukemia.
Hewamana S; Lin TT; Rowntree C; Karunanithi K; Pratt G; Hills R; Fegan C; Brennan P; Pepper C
J Clin Oncol; 2009 Feb; 27(5):763-9. PubMed ID: 19124804
[TBL] [Abstract] [Full Text] [Related]
9. Genome-wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletion.
Forconi F; Rinaldi A; Kwee I; Sozzi E; Raspadori D; Rancoita PM; Scandurra M; Rossi D; Deambrogi C; Capello D; Zucca E; Marconi D; Bomben R; Gattei V; Lauria F; Gaidano G; Bertoni F
Br J Haematol; 2008 Nov; 143(4):532-6. PubMed ID: 18752589
[TBL] [Abstract] [Full Text] [Related]
10. Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia.
Ferreira BI; García JF; Suela J; Mollejo M; Camacho FI; Carro A; Montes S; Piris MA; Cigudosa JC
Haematologica; 2008 May; 93(5):670-9. PubMed ID: 18367492
[TBL] [Abstract] [Full Text] [Related]
11. Acute graft-versus-host disease. The incidence and risk factors.
Wojnar J; Giebel S; Krawczyk-Kulis M; Markiewicz M; Kruzel T; Wylezol I; Czerw T; Seweryn M; Holowiecki J
Ann Transplant; 2006; 11(1):16-23. PubMed ID: 17025025
[TBL] [Abstract] [Full Text] [Related]
12. GM-CSF stimulates proliferation of clonal leukemic bone marrow cells in acute myeloid leukemia (AML) in vitro.
Schmetzer HM; Gerhartz HH; Wilmanns W
Ann Hematol; 1999 Oct; 78(10):449-55. PubMed ID: 10550555
[TBL] [Abstract] [Full Text] [Related]
